Balaji Amines Summonsed Over Alleged Drugs & Cosmetics Act Violations

Balaji Amines Limited has been summoned by the Court of the Honourable Additional Principal Judge in Ahmedabad, along with all its directors, to appear on December 4, 2025, over alleged violations of the Drugs and Cosmetics Act, 1940. The summons, issued on November 11 and received by the company on November 23, cites multiple sections including 16(1)(a), 18(a)(i), 18(c), 27(b)(ii), 27(d), and 34—pertaining to manufacturing, quality control, and regulatory compliance. The company has stated that it will comply with the notice—either through personal appearance or legal representation—and asserts that there is no material impact on its financials or operations at this stage. It also clarified that no additional legal documents have been received beyond the summons. While Balaji Amines downplays immediate risks, investors are advised to monitor the case closely, as potential outcomes could include fines, reputational impact, or operational restrictions. The proceedings mark a regulatory scrutiny phase for the chemical manufacturer, with implications hinging on the final court decision.